Your search returned 70 studies. (Get alerts for new studies):
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Conditions: Kidney Neoplasms - Carcinoma, Renal Cell - Kidney (Renal Cell) Cancer
1 Location available
- Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Neoplasm Metastases
3 Locations available
- A Phase I Study of Ridaforolimus and Vorinostat in Patients With Advanced Renal Cell Carcinoma (RCC)
Conditions: Advanced Renal Cell Carcinoma
1 Location available
- Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Conditions: Kidney Cancer
1 Location available
- BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)
Conditions: Renal Cancer
1 Location available
- Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Conditions: Carcinoma, Renal Cell
1 Location available
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Pharmacokinetics of AGS-16M8F
3 Locations available
- Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma - Osteosarcoma - Astrocytoma - Atypical Teratoid/Rhabdoid Tumor - Ependymoma - Germ Cell Tumor - Glioma - Medulloblastoma - Rhabdoid Tumor - Retinoblastoma - Clear Cell Sarcoma - Renal Cell Carcinoma - Wilms Tumor - Hepatoblastoma - Neurob
1 Location available
- Cardiovascular Effects of Sunitinib Therapy (CREST)
Conditions: Patients With Renal Cell Carcinoma Who Are Newly Initiating Therapy - With the Oral Tyrosine-kinase Inhibitor Sunitinib.
1 Location available
- Association Between Hepatitis C Infection and Renal Cell Carcinoma
Conditions: Hepatitis C - Renal Cell Carcinoma - Colorectal Cancer
1 Location available
- AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma - Clear Cell Renal Carcinoma - Clear Cell Renal Cell Carcinoma - Renal Cell Carcinoma
3 Locations available
- Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma - Kidney Neoplasm - Renal Cancer - Kidney Cancer
1 Location available
- Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy
Conditions: Kidney Cancer
1 Location available
- Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors an
Conditions: Advanced Renal Cell Carcinoma - Gastrointestinal Stromal Tumors - Pancreatic Neuroendocrine Tumors
1 Location available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Hemangioblastoma - Hereditary Neoplastic Syndrome - Hippel Lindau Disease - Neoplasm - Renal Cell Carcinoma
1 Location available
- Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell Ca
Conditions: Histological Evidence of Metastatic Clear Cell Renal Cell Carcinoma - That Has Been Previously Treated With 1-3 Prior Regimens. Phase 1 Only, Any Number of Prior Regimens - With Evidence of Progressive Disease on or Within 6 Months - of Discontinuing Suni
1 Location available
- Phase II Study of Alternating Sunitinib and Temsirolimus
Conditions: Metastatic Renal Cell Carcinoma
1 Location available
- Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome
1 Location available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
Conditions: Metastatic Renal Cell Carcinoma
1 Location available
- Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage IV Renal Cell Cancer
2 Locations available
- Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
1 Location available
- BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Clear-cell Metastatic Renal Cell Carcinoma
5 Locations available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Kidney Cancer
3 Locations available
- Genetic Susceptibility to Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- Metastasectomy Study in Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Conditions: Renal Cell Carcinoma - Metastatic Renal Cell Carcinoma
2 Locations available
- Interleukin 2, Aldesleukin and Entinostat for Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Pri
Conditions: Metastatic Renal Cell Carcinoma
5 Locations available
- Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage I Renal Cell Cancer - Stage II Renal Cell Cancer - Stage III Renal Cell Cancer
3 Locations available
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low- or Intermediate-Grade Neuroendocrine Cancer
Conditions: Extra-Adrenal Paraganglioma - Gastrointestinal Carcinoid Tumor - Head and Neck Cancer - Islet Cell Tumor - Lung Cancer - Neuroendocrine Carcinoma of the Skin - Pheochromocytoma
1 Location available
- BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
1 Location available
- Effect of Sorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Conditions: Renal Cell Carcinoma - Hepatocellular Carcinoma
1 Location available
- PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
1 Location available
- Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Renal Cancer
2 Locations available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Conditions: Advanced Non-clear Cell Renal Cell Carcinoma
9 Locations available
- Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
1 Location available
- Brivanib Metastatic Renal Cell Carcinoma
Conditions: Male and Female Subjects 18 Years of Age and Older With Metastatic Renal Cell Carcinoma. Eligible Patients Must Have Undergone and Failed Prior Treatment.
1 Location available
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
1 Location available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
7 Locations available
- Phase I Biomarker Study (BMS-936558)
Conditions: Renal Cell Carcinoma
10 Locations available
- Neoadjuvant Pazopanib in Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib M
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
3 Locations available
- Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Sunitinib In Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cancer
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
3 Locations available
- Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma - Liver Cancer - Adrenal Cancer
2 Locations available
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
18 Locations available
- A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
20 Locations available
- A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Clear Cell Renal Cell Carcinoma
18 Locations available
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Conditions: Metastatic Renal Cell Carcinoma - Metastatic Melanoma
2 Locations available
- PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
Conditions: Renal Cell Carcinoma
1 Location available
- Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Conditions: Kidney Cancer
2 Locations available
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
24 Locations available
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
40 Locations available
- Renal Cell Carcinoma (RCC) Scramble
Conditions: Renal Cell Carcinoma
1 Location available
- A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Cancer
47 Locations available
- PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
33 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
|